Skip to main content
VCbacked
Log inGet Started

Alesta Therapeutics

Leiden, The Netherlands

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

$67.0M raised
Jan 2025
Series A
Biotechnology

Top Investors

RTW InvestmentsFrazier Life SciencesNovartis Venture FundThuja CapitalDroia Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Alesta Therapeutics

How much funding has Alesta Therapeutics raised?
Alesta Therapeutics has raised $67.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Who are Alesta Therapeutics's investors?
Alesta Therapeutics's investors include RTW Investments, Frazier Life Sciences, Novartis Venture Fund, Thuja Capital, Droia Ventures.
Where is Alesta Therapeutics headquartered?
Alesta Therapeutics is headquartered in Leiden, The Netherlands.
What does Alesta Therapeutics do?
Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
What stage is Alesta Therapeutics at?
Alesta Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Alesta Therapeutics — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/alesta-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Alesta Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/alesta-therapeutics
Wikipedia (cite web)
{{cite web |title=Alesta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/alesta-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K